Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$46.98−0.91 (-1.90%)
Close on Nov 12, 2026Market cap $7.88BP/E 123.6Yield –
Alkermes market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Alkermes's market cap was $8.02B on Nov 11, 2026, against $4.88B a year earlier. Over the last 5 years it ranged from $3.67B to $8.72B, with a median of $4.69B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.02B | +73.7% |
| 2025 | Dec 31, 2025 | $4.62B | -0.7% |
| 2024 | Dec 31, 2024 | $4.65B | +0.6% |
| 2023 | Dec 29, 2023 | $4.62B | +7.7% |
| 2022 | Dec 30, 2022 | $4.29B | +14.2% |
| 2021 | Dec 31, 2021 | $3.76B | +18.5% |
| 2020 | Dec 31, 2020 | $3.17B | -1.2% |
| 2019 | Dec 31, 2019 | $3.21B | -29.9% |
| 2018 | Dec 31, 2018 | $4.58B | -45.5% |
| 2017 | Dec 29, 2017 | $8.41B | -0.3% |
| 2016 | Dec 30, 2016 | $8.44B | -29.1% |
| 2015 | Dec 31, 2015 | $11.90B | +51.9% |
| 2014 | Dec 31, 2014 | $7.83B | +44.0% |
| 2013 | Dec 31, 2013 | $5.44B | +123.2% |
| 2012 | Dec 31, 2012 | $2.44B | +8.3% |
| 2011 | Dec 30, 2011 | $2.25B | +93.2% |
| 2010 | Dec 31, 2010 | $1.16B | – |
See a number that looks wrong?